Overview
- 86 inspections across 81 sites are on record.
- 197 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2021-04-06.
At a glance
Inspections
86
Sites
81
Observations
197
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Cyclomedica Australia Pty Limited | 6 Apr 2021 | Human Drugs | On file |
| Vega Life Sciences | 28 Nov 2019 | Human Drugs | On file |
| UMEDICA LABORATORIES PRIVATE LIMITED | 5 Jul 2019 | Human Drugs | |
| Eugia Pharma Specialities Limited | 14 Dec 2018 | Human Drugs | On file |
| Akorn Inc. | 30 Aug 2018 | Human Drugs | On file |
Sites inspected
Cyclomedica Australia Pty LimitedKingsgrove, Australia1 insp.
Vega Life SciencesHyderabad, India1 insp.
UMEDICA LABORATORIES PRIVATE LIMITEDVapi, India1 insp.
Eugia Pharma Specialities LimitedSangareddy, India1 insp.
Akorn Inc.Somerset, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Addam S Reynolds8 shared
Peter E Baker7 shared
Jose M Cayuela6 shared
Nicholas A Violand6 shared
Jessica M Monteiro5 shared
Barbara J Wilimczyk-Macri4 shared
Michelle M Parisi4 shared
Dipesh K Shah3 shared
Lauren L Vajo3 shared
Paul L Bellamy3 shared
Full investigator report
Get the verbatim findings behind Atul Agrawal's 197 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site